Leveraging an equity research team based in London and in Paris, our expertise is a fundamental bottom-up approach applied to a well-defined universe of growth companies. We cover a broad range of small to large market capitalisations, within our five focus sectors (TMT, Healthcare, Consumer Brands & Retail, Smart Industries & Energy and Business Services & Outsourcing). Together, they altogether represent over 50% of the total European market capitalisation.
Our Equity Research team tracks close to 200 stocks across our European Equity Growth universe. This highly focused approach enables the generation of Buy and Sell recommendations for companies where the team has strong convictions. Our analysts have clear-cut opinions and publish over 100 initiation reports and major updates per year.
Bryan, Garnier & Co is a dynamic pan-European investment bank, focused on growth markets. As such, our institutional sales and trading teams enjoy privileged relationships with a wide variety of asset managers who are typically growth-oriented and focused on Europe.
Bryan, Garnier & Co established its derivatives practice in 2011, advising clients on investment decisions with tailored research notes and trading ideas covering equity derivatives (options and futures), synthetic products, fixed income and foreign exchange.